Volume 15 - Issue 1 - January, 2003
Editorial Message
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers,
This issue of the Journal of Invasive Cardiology includes original research articles, case reports, articles from the Journal special sections “Acute Coronary Syndromes” and “Intervention in Peripheral Vascular Disease”, and a...
Dear Readers,
This issue of the Journal of Invasive Cardiology includes original research articles, case reports, articles from the Journal special sections “Acute Coronary Syndromes” and “Intervention in Peripheral Vascular Disease”, and a...
Dear Readers,
This issue of the...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Kirk N. Garratt, MD, MSc; Peter B. Berger, MD; David R. Holmes, Jr., MD; Panayotis Fasseas, MD; Ali E. Denktas, MD; James L. Orford, MBChB, MPH, MD; LaVon Hammes; Gregory W. Barsness, MD
There have been rapid improvements in percutaneous coronary intervention since its introduction. However, complex lesions unsuitable for routine angioplasty continue to pose a significant problem. A number of alternative devices have been...
There have been rapid improvements in percutaneous coronary intervention since its introduction. However, complex lesions unsuitable for routine angioplasty continue to pose a significant problem. A number of alternative devices have been...
There have been rapid...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Francis Q. Almeda, MD; Lloyd W. Klein, MD
The Cutting Balloon is an interventional device with 3–4 sharp microtome metal blades mounted longitudinally on the balloon surface. The microsurgical blades on the cutting balloon allow a more controlled dissection with lower inflation...
The Cutting Balloon is an interventional device with 3–4 sharp microtome metal blades mounted longitudinally on the balloon surface. The microsurgical blades on the cutting balloon allow a more controlled dissection with lower inflation...
The Cutting Balloon is an...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Ryan J. Lennon, MS; Malcolm R. Bell, MD; Kirk N. Garratt, MD, MSc; David R. Holmes, Jr., MD; Christopher H. Crocker, MPAS; Kevin T. Cragun, MD; Farris K. Timimi, MD; Robert J. Houlihan, MD; Henry H. Ting, MD, MBA
Achieving arterial hemostasis is a major factor limiting ambulation and hospital discharge among patients undergoing diagnostic cardiac catheterizations. Historically, manual or mechanical compression for 15–30 minutes coupled with an...
Achieving arterial hemostasis is a major factor limiting ambulation and hospital discharge among patients undergoing diagnostic cardiac catheterizations. Historically, manual or mechanical compression for 15–30 minutes coupled with an...
Achieving arterial hemostasis is...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Zoltan G. Turi, MD
Crocker et al., in this issue of the Journal, have demonstrated a close to 90% success rate with immediate (See Crocker et al. on pages 728–732
repeatedly raised by skeptics of vascular device closure: why expose the patient to potential...
Crocker et al., in this issue of the Journal, have demonstrated a close to 90% success rate with immediate (See Crocker et al. on pages 728–732
repeatedly raised by skeptics of vascular device closure: why expose the patient to potential...
Crocker et al., in this issue of...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Pavel Cervinka, MD, PhD; Joseph Stasek; Miloslav Pleskot; Jaroslav Maly
Treatment of bifurcation lesions still remains a challenge for interventional cardiologists and is still associated with a high rates of complications (8–22%) and restenosis (30–65%).1–5 The presence of a large plaque burden at the site of...
Treatment of bifurcation lesions still remains a challenge for interventional cardiologists and is still associated with a high rates of complications (8–22%) and restenosis (30–65%).1–5 The presence of a large plaque burden at the site of...
Treatment of bifurcation lesions...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Nurit Shor, RN; Alexander Battler, MD; Ran Kornowski, MD; Simcha Brandes, MD; Abid R. Assali, MD; Igal Teplitsky, MD; Eldad Rechavia, MD
Arterial access site management after percutaneous coronary intervention (PCI) is a matter of increasing importance in this era of more complex procedures with frequent use of potent antiplatelet pharmacotherapy.1 The morbidity associated...
Arterial access site management after percutaneous coronary intervention (PCI) is a matter of increasing importance in this era of more complex procedures with frequent use of potent antiplatelet pharmacotherapy.1 The morbidity associated...
Arterial access site management...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
V.S. Srinivas, MBBS; Babak A. Vakili, MD; David L. Brown, MD, FACC, FACP, DO
Rapid reperfusion with fibrinolytic drugs following acute myocardial infarction (AMI) is associated with increased myocardial salvage and improved survival.1,2 However, the efficacy of these agents begins to diminish when they are...
Rapid reperfusion with fibrinolytic drugs following acute myocardial infarction (AMI) is associated with increased myocardial salvage and improved survival.1,2 However, the efficacy of these agents begins to diminish when they are...
Rapid reperfusion with...
08/01/2008
Journal of Invasive Cardiology
Vascular Disease
08/01/2008
Michael L. Marin, MD; Sharif Ellozy, MD; Nicholas J. Morrissey, MD; Peter L. Faries, MD; Alfio Carrocio, MD; Victoria Teodorescu, MD; Larry H. Hollier, MD
EDITORIAL NOTE — The authors have succeeded in providing a complete and yet concise summary of all the important issues concerning occlusion/exclusion of hypogastric arteries (HA) in the context of endovascular repair of aorto-iliac...
EDITORIAL NOTE — The authors have succeeded in providing a complete and yet concise summary of all the important issues concerning occlusion/exclusion of hypogastric arteries (HA) in the context of endovascular repair of aorto-iliac...
EDITORIAL NOTE — The authors...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Hugo A. Katus, MD; Volker Geist, MD; Gert Richardt, MD, PhD; Deepak Jain, MD, DM
Atherosclerotic coronary artery disease (CAD) is seen in 25% patients with hypertrophic cardiomyopathy (HCM) aged more than 45 years1 and this association presents an intriguing problem to a clinician from both diagnostic and therapeutic...
Atherosclerotic coronary artery disease (CAD) is seen in 25% patients with hypertrophic cardiomyopathy (HCM) aged more than 45 years1 and this association presents an intriguing problem to a clinician from both diagnostic and therapeutic...
Atherosclerotic coronary artery...
08/01/2008
Journal of Invasive Cardiology
